Clinical trial
PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function With 10 kHz SCS in Treatment of Painful Diabetic Neuropathy
NCT05777317 is registered in ClinicalTrials.gov with Nevro Corp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function With 10 kHz SCS in Treatment of Painful Diabetic Neuropathy
- Lead sponsor
- Nevro Corp
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 24, 2023
- Completion date
- July 31, 2026
- Enrollment
- 143 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
painful diabetic neuropathy